The use of so-called ‘compulsory licenses’ by developing countries to obtain cheaper drugs for HIV and AIDS by circumventing patents has not been the best strategy for achieving the lowest prices over the past decade, a new study claims. Instead, the best prices were often obtained by countries that procured their drugs through voluntary negotiations, […]